Advertisement
Screener

VSee Health, Inc. (VSEE) Overview

VSee Health, Inc. (VSEE) Overview

  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.05; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.02; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.16; Beat / miss (m).
  • 1 Jan 2025: Period ending 31 Mar 2025; Estimate (m); Actual -0.24; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.02$0.05$0.11$0.26$0.61$1.452025-08-272026-08-27$0.02$0.08$0.32$1.31$5.38$22.062021-12-312026-08-27$0.02$0.08$0.32$1.31$5.38$22.062021-12-312026-08-27$0.02$0.08$0.32$1.31$5.38$22.062021-12-312026-08-27$0.02$0.08$0.32$1.31$5.38$22.062021-12-312026-08-27

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.02
Previous close
$0.02
Change
$0.00
Change (%)
0.00%
Close date
2026-08-27
Previous close date
2026-08-26
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-08-27

YTD

VSEE
-94.59%
S&P 500
(m)

1 year

VSEE
-97.65%
S&P 500
(m)

3 years

VSEE
-99.83%
S&P 500
(m)

5 years

VSEE
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Mar 2026 ○ Estimate (m) ● Actual -0.05

-3.66-2.71-1.75-0.790.1630 Sept 2024: estimate (m); actual -3.5830 Sept 2024(m)31 Mar 2025: estimate (m); actual -0.2431 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1630 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0230 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.0531 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202631 Mar 2026(m)-0.05(m)(m)
1 Jul 202530 Sept 2025(m)-0.02(m)(m)
1 Apr 202530 Jun 2025(m)-0.16(m)(m)
1 Jan 202531 Mar 2025(m)-0.24(m)(m)
1 Jul 202430 Sept 2024(m)-3.58(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.73

-5.73-4.32-2.90-1.49-0.0731 Dec 2022: estimate (m); actual -0.2531 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.3831 Dec 2023(m)31 Dec 2024: estimate (m); actual -5.6531 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.7331 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.73(m)(m)
1 Jan 202431 Dec 2024(m)-5.65(m)(m)
1 Jan 202331 Dec 2023(m)-0.38(m)(m)
1 Jan 202231 Dec 2022(m)-0.25(m)(m)

Revenue vs. Earnings

USD

31 Mar 2026 ■ Revenue 3.16M ■ Earnings -2.60M — Profit margin -82.28%

-9.27M-248.7%-4.38M-167.9%0.51M-87.1%5.40M-6.3%30 Jun 2025: revenue 1.06M; earnings -2.61M; profit margin -247.66%30 Jun 202530 Sept 2025: revenue 3.98M; earnings -0.29M; profit margin -7.28%30 Sept 202531 Dec 2025: revenue 3.93M*; earnings -7.85M*; profit margin -199.96%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 3.16M; earnings -2.60M; profit margin -82.28%31 Mar 2026

31 Dec 2025 ■ Revenue 14.62M ■ Earnings -14.71M — Profit margin -100.65%

-66.38M-554.7%-36.49M-391.2%-6.60M-227.7%23.30M-64.3%31 Dec 2023: revenue 5.77M; earnings -3.76M; profit margin -65.26%31 Dec 202331 Dec 2024: revenue 10.42M; earnings -57.70M; profit margin -553.69%31 Dec 202431 Dec 2025: revenue 14.62M; earnings -14.71M; profit margin -100.65%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.02(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.02High(m)Average(m)Low(m)2025-08-272026-08-27

Recent news

View more →

(m)

YouTube videos mentioning VSEE

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-13.51M
Profit margin
-85.50%
Return on assets · 12 month
-77.35%
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
85.24K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-33.33%*
Total return · month
-75.00%*
Total return · quarter
-91.30%*
Total return · half year
-94.59%*
Total return · year to date
-94.59%*
Total return · 1 year
-97.65%*
Total return · 3 years
-99.83%*
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$15.81M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

VSee Health, Inc. Overview

View more →

(m)

(m)

SEC CIK
1864531
Industry (SIC)
8000 Services-Health Services
Country of operation
United States
Business address
980 N FEDERAL HWY, #304, BOCA RATON, Florida, 33432, United States
Fiscal year end
1231
Phone
5616727068

Similar stocks

Stock NameCountryMarket CapPE Ratio
Agape ATP Corp (ATPC)$0.002B
DocGo Inc. (DCGO)United States$0.034B-0.25
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86